INTRODUCTION
The most prevalent oral mucosal lesions are aphthous ulcerations commonly referred to as "canker sores". The clinical characteristic of oral recurrent aphthous ulceration/stomatitis (ORAS) is well defined and can be partly described as an oval or rounded ulcer covered by a grey-white or yellowish fibrinous exudate and surrounded by an erythematous halo. There is intense or moderate pain and the ulcers heal in about 10 -14 days for the more common type and more than 2 weeks for the severe type.
Recurrence of the ulcers occurs at intervals within a year or over several years(l). Variations of ORAS described above have made studies on aetiology and treatment difficult to interpret due to differing descriptions of differing diseases with similar clinical signs and symptoms and possibly differing aetiologies. A classification that was considered useful as a working model for ORAS was formulated in 1978 (2) . While the classification of ORAS had been widely accepted since 1978, the cause for ORAS is still unknown and its aetiology in general remains unclear. However, its immunopathogenesis is now becoming more clearly defined as evidenced and described by many researchers (3) .
CLASSIFICATION
The term aphthae was first used by Hippocrates( 460-370BC) in relation to disorders of the mouth. However, only in 1898 that the first clinical description of this term was documented by von Mikulicz and Kummel(4). They described 'Mikulicz aphthae' which is now synonymous with minor aphthous ulcers. In 1911, Sutton further described another type of recurrent ulcers termed 'periadenitis mucosa necrotica recurrens'(l). Herpetiform ulcer was described by Cooke in 1961 and is now regarded as one of the recurrent ulcers but separate from the aphthous ulcers. The name herpetiform ulcers denotes multiple small ulcers per attack mimicking a true herpetic lesionbut is not caused by Herpes virus( 1).
Many researchers described ORAS as being a disease of the oral mucosa characterized by recurrent, painful, single or multiple well-demarcated ulceration with peripheral red halo where healing takes place with or without scarring. These varied clinical presentations and the occurrence of some in mucocutaneous-ocular syndromes led to a classification proposed by Donatsky in 1973(5 Except for the terminology used, the latter classification was similar to that described by Donatsky in 1973(5) where 'minor aphthous ulcer' is synonymous 'stomatitis aphthosa recurrens', 'major aphthous ulcer' is synonymous with 'stomatitis aphthosa recurrens cicatricicans' and 'herpetiform ulcer' is synonymous with 'stomatitis aphthosa recurrens herpetiformis'. Mucocutaneous-ocular syndromes with aphthous-like stomatitis as classified by Donatsky (5) were not included in this classification of 1978. Instead, a similar condition was recognized as its own entity called Behcet's syndrome that was classified separately into different subtypes as below: 1. Muco-cutaneous( oral and genital lesions with or without skin lesions) 2. Arthritis( oral, genital and skin lesions with arthritis) 3. Neuro-ocular(oral, genital and skin lesions and neurological symptoms) EPIDEMIOLOGY Different types of prevalence had been used for studies on ORAS by different investigators. In view of the natural history and recurrent nature of these lesions, crosssectional clinical surveys tend to underestimate the true prevalence of an ORAS, as active lesions may not be present at the time of the examination(6). Three types of prevalence have been used and reported in the literature for aphthous ulcers namely the prevalence for 'current ulcers', for 'history of ulcers (throughout life)'and 'history of ulcers (within the last 2 years)' (7, 8) . The prevalence for 'current ulcers' can be considered as average point prevalence (APP) where the presence of the ulcer/ulcers was detected at the time of the oral examination. The prevalence for 'history of ulcers (throughout life)' can be considered as self-reported lifetime prevalence (SRLP) where the subjects were asked whether they have ever had such ulcers. The prevalence for 'history of ulcers (within the last 2 years)'can be considered as a self-reported twoyear prevalence (SRTP) where the subjects were asked whether they ever had such ulcers within the last 2 years(9). Variation in prevalence reported in different studies can partly be attributed to the usage of differing type of prevalence. For example, in Axell's study consisting of 20,333 Swedish population above 15 years old, the APP of ORAS was found to be lower (2%) than the SRTP (17.7%) (8) . Such result would be expected as the APP of clinically present ulcers represent only a small component of either SRTP or SRLP since the chances of capturing aphthous ulcers on a given day are small (6) . For the purpose of discussing and comparing prevalence of ORAS in this paper, the terms APP, SRLP and SRTP will be used.
Samples selected for the study of ORAS may also be a contributing factor to the variation of prevalence of ORAS between studies. Most of the studies on ORAS prevalence have used samples of convenience such as health professionals/dental and medical students(7), schoolchildren( 6), clinic/hospital-based patients( I 0-12), industrial workers(13) and army personnel (14) . As the predisposing factors for ORAS includes systemic and genetic factors, the wide variations observed between these studies can also be attributed to differing samples selected (7) .
Similarly, samples studied maybe age biased. Kleinmann et al had shown that the age-specific SRLP of ORAS ranged from about 21.7% at age 6 to 41.1% at age 17 in a study of39,206 U.S. schoolchildren (6) .
In general, the prevalence (mostly the minor type) of ORAS that has been reported in the literature varies from 0.4 -66% (15,17) ). The lowest prevalence of 0.4 % was a SRTP+APP and was reported by Taiyeb Ali et al in elderly(>60 years) Malaysian. The highest prevalence of 66% was a SRLP in a study by Ship et al (1967) (15) on dental and medical students.
A search of the literature showed that only 3 ORAS prevalence studies were conducted on the general population worldwide. One study was conducted in a random sample of Danish over 65 years of age where the APP of ORAS was I %. A study by Axell in 20,333 Swedish county residents above 15 years of age showed the SRTP + APP of 19.7% (8) . Fahmy found that the SRLP of ORAS was 18% in 9000 Kuwaiti Arabs, 35 % in 11,000 Non-Kuwaiti Arabs and a low SRLP of 5.0% in Bedouins (16) . Very recently Zain reported an APP of 0.5% in 11,697 randomly selected Malaysian population (9) .
The SRLP of ORAS in professionals/professional school student groups varies from 43.1 % in 10,531 Health Sciences students in 21 countries(7) to 66.2% in 343 medical/dental students in the United States (15) . Two other studies from the United States on these population groups were on 1,788 Professional school students and 704 Health professionals where the SRLP were 55.0% and 50.7% respectively (7, 15) .
The SRLP of ORAS in 1,738 medical and surgical patients of all ages in the United Kingdom was found to be 19.3% (10) which is lower than the SRLP in dental clinic outpatients. The SRLP of ORAS in 3,106 dental clinic outpatients from a Thai dental school was found to be 46.7% (12) while the SRTP+APP of 48.3% was found in 234 dental clinic outpatients in a similar study in another Thai dental school(11).
In Malaysia, 2 studies were conducted on dental clinic outpatients. One was on 233 dental clinic outpatients from a dental school where the SRTP +APP was 27.0%(11) while the other was on 999 dental clinic outpatients from a government dental clinic where the SRTP + APP was 28.0% (18) . Among factory workers in Malaysia, the SRTP+APP was found to be 38.9% for glass factory workers and 56.5% for steelmill workers (13) . Another study in Malaysia was conducted on 1013 army personnel (all men) where the SRTP+APP for ORAS was 19.9% (14) . This value seemed lower than most of the other Malaysian studies and maybe due to the fact that all the subjects were men. Some studies have shown that the prevalence of ORAS was more frequent in women than men (19) .
The prevalence of ORAS also varied tremendously depending on the age range of the population selected. Axell's study on the Swedish population had shown a higher prevalence of 26.7% in the 15-24 age group as compared to 7.5 % in the 65-74-age group (8) . Similar age-specific prevalence was also reported in US schoolchildren(6) where they observed the SRLP ranging from 21.7% at age 6 years to 41.1 % at age 17 years. Ferguson et al had also shown such differences in the prevalence of 25-30 year old women (25.4%) and 45-56 year old women (6.1 %) (19) .
In summary, the prevalence of ORAS is dependent on whether it is that of current ulcers or selfreported life or 2-years prevalence. Age and gender distribution of the subjects and type of population studied can also influence the prevalence of OR AS.
AETIOLOGY
The aetiology of ORAS is unknown and remains unclear. Other than the presence of ulcers and pain experienced for some patients, most of these patients are generally well. Many studies have shown that ORAS has many predisposing factors. In about 10 -20 % of patients, deficiencies of iron, folic acid or vitamin B 12 was reported. About 2-3% of patients with ORAS were related to coeliac disease (gluten-sensitive enteropathy)(20) Haematinic deficiencies seemed to be secondary to coeliac disease.
Other underlying systemic diseases and immunodeficiencies presenting with aphthous-like oral ulcers are agranulosytosis, neutropenias (cyclic and
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neutropenia from other causes such as autoimmune neutropenia) and HIV-seropositive patients. The association of Behcet's Syndrome and its variants with reCLllTentaphthous stomatitis have long been recognized and documented. Oral ulcerations similar to ORAS may also be associated with other syndromes such as Sweet's syndrome (acute febrile neutrophilic dermatosis-raised erythematous plaques on face, neck, chest and extremities accompanied by fever and general malaise), MAGIC syndrome/F AP A Syndrome (fever, aphthous, pharyngitis and cervical adenitis) (20) (21) ' In a small group of women with ORAS, cyclical oral ulceration occurred in relation to the luteal phase of the menstrual cycle and presumedly modulated by changing levels of progesterone since the occurrence of ORAS in these cases appears unrelated to psychologic factors(l9,20). Many researchers have indicated stress as one of the predisposing factor for ORAS in some susceptible people. However, there are insufficient data supporting this (21) .
Food allergy (hypersensitivity reactions to exogenous antigens) has been suggested as having a potential role in causing ORAS (20) . However, at a recent meeting Report of the third European Congress of Oral Medicine, it was summarized that hypersensitivity reaction to exogenous antigen other than gluten does not have a significant role in ORAS (21) . There has also been evidence of a familial basis in some of these susceptible individuals where patients with a family history may develop ORAS at an earlier age and with more severe symptoms than those without a family history. There is also a high correlation of ORAS in identical twins as compared to non-identical twins (20) . However, studies of patients of different ethnic groups have failed to show significant associations between a serologically determined HLA antigen and susceptibility of ORAS, thus making the immunogenetic basis questionable. There is also now evidence that drugs such as the non-steroidal anti-inflammatories can also give rise to aphthous-like ulcers. ORAS may also be initiated by local factors such as trauma in susceptible person. In areas of mucosal keratinization, ORAS is uncommon (21) .
This further explained reports that the prevalence of ORAS is lower in smokers(ll) since smoking causes keratinization of the oral mucosa.
Eventhough there are reports of immunological changes in ORAS, evidence for ORAS as an autoimmune disease is so far lacking or unreliable (21) . There appears to be a genetically determined immunological reactivity to unidentified antigens. The latter is most probably microbial and such aetiology has long been suggested while the search for a viral cause has been and is still ongoing (3) . Eventhough Varicella-zoster virus and Cytomegalovirus IgM antibody titers are increased during ulcer recurrences, intralesional viral antigens and DNA have not been identified. It has been suggested based on past and current evidence that ORAS may be due to changes in cell-mediated immune responses and crossreactivity with Streptococcus sanguis (S. sanguis) or a heat shock protein. The L-form of S. sanguis was initially isolated from ORAS patients and further analysis showed this to be a strain of S. mitis. A cross-reactivity between a streptococcal 60-65 kDA heat shock protein and the oral mucosa has been demonstrated as well as significantly raised levels of antibodies to heat shock protein in ORAS patients. The lymphocytes in ORAS patients also have reactivity to a heat shock protein peptide. Cross-reactivity between the 65 kDa heat shock protein and the 60kDa human mitochondrial heat shock protein lead to a T cellmediated response to antigens of S. sanguis that cross react with mitochondrial heat shock protein and inducing oral mucosal damage (21) .
The immunopathogenesis of GRAS seemed more clearly defined. A variety of adhesion molecules are expressed in ORAS and probably control the movement of leukocytes up into the epithelial layer where leukocytemediated keratinocyte lysis occurs(3). Cytotoxic T-cells respond to oral keratinocyte-associated antigen (a target antigen residing within the epithelial compartment). Once on-site, a variety of Iymphokines including tumour necrosis factor (thought to play a role in the cytolytic process) are released. As the lesion progress to ulcers, there is an increase in local cytotoxic cell population and (presumedly cytokine related) increased expression of HLA class I and II antigen on epithelial cells. Current evidence suggested that immunologically mediated cytotoxicity of the oral epithelium is important in the development of ulcers in ORAS (21) .
